Consider and Approved Standalone and Consolidated Audited Financial Results for the year ended March 31, 2025 along with Limited Review Report given by the Statutory Auditor of the Company ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Hipolin Ltd's board, meeting on May 29, 2025, approved audited standalone and consolidated results for FY25 with an unqualified opinion from auditor SDPM & Co. Total income grew about 8.5% to Rs 2,193.43 lakhs (standalone), driven by revenue from operations rising to Rs 2,156.42 lakhs from Rs 1,973.12 lakhs. However, the company swung into a much deeper net loss of Rs 327.75 lakhs versus Rs 88.61 lakhs in FY24, with EPS worsening to Rs (10.47) from Rs (2.83). Costs surged: total expenses rose nearly 20% to Rs 2,521.18 lakhs, with other expenses jumping roughly 49% to Rs 688.52 lakhs and finance cost nearly tripling to Rs 24.50 lakhs. Operating cash flow remained deeply negative at Rs (318.23) lakhs, and reserves eroded from Rs 828.93 lakhs to Rs 501.18 lakhs.
Despite modest revenue growth, shareholders face sharply worsening profitability, with the net loss nearly quadrupling year-on-year and reserves being significantly depleted. The widening cost base versus revenue, combined with sustained negative operating cash flows, is a negative signal for near-term stock sentiment.